CRO Sector Stocks Show Robust Gains in Early Trading Session

Deep News06-24 10:40

Stocks within the Contract Research Organization (CRO) concept displayed notable strength during the morning trading session.

As of the time of writing, Asymchem Laboratories(Tianjin)Co.,Ltd. (ASX: 06821) had surged by 14.05%, reaching HK$110.40.

GENSCRIPT BIO (ASX: 01548) saw an increase of 8.56%, trading at HK$11.80.

WuXi AppTec Co., Ltd. (ASX: 02359) also rose by 8.56%, with its share price at HK$142.

Tigermed Consulting Co., Ltd. (ASX: 03347) advanced by 5.67%, quoted at HK$32.74.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment